Home LiteratureArticle Details
PMID: 2158102 Published · ppublish English Journal Article

Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.

Egberink H, Borst M, Niphuis H, Balzarini J, Neu H, Schellekens H, De Clercq E, Horzinek M, Koolen M

Abstract

The acyclic purine nucleoside analogue 9-(2-phosphonomethoxyethyl)adenine [PMEA; formerly referred to as 9-(2-phosphonylmethoxyethyl)adenine] is a potent and selective inhibitor of human immunodeficiency virus replication in vitro and of Moloney murine sarcoma virus-induced tumor formation in mice. In the latter system PMEA has stronger antiretroviral potency and selectivity than 3'-azido-3'-thymidine (AZT). We have now investigated the effect of the drug in cats infected with the feline immunodeficiency virus (FIV). In vitro, PMEA was found to efficiently block FIV replication in feline thymocytes (50% effective dose, 0.6 microM). When administered to cats at doses of 20, 5, or 2 mg/kg per day, PMEA caused a dose-dependent suppression of FIV replication and virus-specific antibody production. Seropositive field cats with signs of opportunistic infection (gingivitis, stomatitis, and diarrhea) showed clinical improvement during PMEA therapy (5 mg/kg per day) and recurrence of the disease after treatment was discontinued. Thus, FIV infection in cats is an excellent model to test the efficacy of selective anti-human immunodeficiency virus agents in vivo.

MeSH Terms
Adenine/analogs & derivatives,pharmacology,therapeutic use Animals Antiviral Agents/therapeutic use Cats Cell Line HIV/drug effects,physiology Immunologic Deficiency Syndromes/complications,drug therapy,microbiology Opportunistic Infections/prevention & control Organophosphonates Retroviridae/drug effects,growth & development,physiology Retroviridae Infections/complications,drug therapy,microbiology T-Lymphocytes/microbiology Virus Replication/drug effects Zidovudine/pharmacology
Chemicals
Antiviral Agents Organophosphonates Zidovudine adefovir Adenine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Egberink H
Department of Infectious Diseases and Immunology, School of Veterinary Medicine, State University of Utrecht, The Netherlands.
Borst M
Niphuis H
Balzarini J
Neu H
Schellekens H
De Clercq E
Horzinek M
Koolen M
References (27)
27 references, click to expand
  1. Re-excretion of feline viral rhinotracheitis virus following corticosteroid treatment.
    Vet Rec. 1973 Aug 18;93(7):204-5 PMID: 4762288
  2. 9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo.
    Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1043-7 PMID: 2559845
  3. Feline respiratory virus carriers in clinically healthy cats.
    Aust Vet J. 1981 Mar;57(3):115-8 PMID: 6266382
  4. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
    Science. 1983 May 20;220(4599):868-71 PMID: 6189183
  5. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
  6. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
    Lancet. 1986 Mar 15;1(8481):575-80 PMID: 2869302
  7. Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.
    Lancet. 1987 Jan 17;1(8525):132-5 PMID: 2879972
  8. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
    Science. 1987 Feb 13;235(4790):790-3 PMID: 3643650
  9. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    N Engl J Med. 1987 Jul 23;317(4):185-91 PMID: 3299089
  10. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    N Engl J Med. 1987 Jul 23;317(4):192-7 PMID: 3299090
  11. Isolation of a T-lymphotropic lentivirus from a persistently leucopenic domestic cat.
    Vet Rec. 1988 Jan 23;122(4):84-6 PMID: 2833000
  12. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.
    Am J Vet Res. 1988 Aug;49(8):1246-58 PMID: 2459996
  13. Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.
    Antimicrob Agents Chemother. 1988 Jul;32(7):1025-30 PMID: 2847636
  14. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.
    Proc Natl Acad Sci U S A. 1989 Jan;86(1):332-6 PMID: 2911579
  15. Feline immunodeficiency virus infection in cats of Japan.
    J Am Vet Med Assoc. 1989 Jan 15;194(2):221-5 PMID: 2537270
  16. Molecular cloning of feline immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2448-52 PMID: 2928341
  17. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
    Intervirology. 1989;30 Suppl 1:12-25 PMID: 2540109
  18. Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
    Intervirology. 1989;30 Suppl 1:26-35 PMID: 2540111
  19. Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis.
    Vet Rec. 1989 Apr 1;124(13):336-8 PMID: 2541529
  20. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    Antimicrob Agents Chemother. 1989 Feb;33(2):185-91 PMID: 2719463
  21. Nucleotide sequence and genomic organization of feline immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1989 Aug;86(15):5743-7 PMID: 2762293
  22. Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.
    Antimicrob Agents Chemother. 1989 Jun;33(6):915-9 PMID: 2475068
  23. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.
    Proc Natl Acad Sci U S A. 1989 Oct;86(20):8088-92 PMID: 2813380
  24. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus.
    J Virol. 1989 Dec;63(12):5483-8 PMID: 2479773
  25. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.
    J Virol. 1990 Feb;64(2):598-606 PMID: 2153226
  26. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
    Antimicrob Agents Chemother. 1989 Nov;33(11):1864-8 PMID: 2482011
  27. Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59).
    Virology. 1981 Jan 30;108(2):424-34 PMID: 6258295
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1990-04-00
Pages
3087-91
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC53839
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]